博济医药：子公司获得药品注册证书

Core Points - The company Boji Pharmaceutical announced that its wholly-owned subsidiary, Guangzhou Huasheng Pharmaceutical Co., Ltd., has received the drug registration certificate from the National Medical Products Administration for "Compound Polyethylene Glycol Electrolyte Powder (III)" [2] Group 1 - The approval of the drug registration certificate marks a significant milestone for the company in expanding its product portfolio [2] - This development may enhance the company's market position in the pharmaceutical industry [2]